Cargando…

Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis

BACKGROUND: Cranial radiation therapy is essential in treating many pediatric cancers, especially brain tumors; however, its use comes with the risk of developing second malignancies. Cranial radiation-induced gliomas (RIGs) are aggressive high-grade tumors with a dismal prognosis, for which no stan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitehouse, Jacqueline P, Howlett, Meegan, Federico, Aniello, Kool, Marcel, Endersby, Raelene, Gottardo, Nicholas G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633655/ https://www.ncbi.nlm.nih.gov/pubmed/34859225 http://dx.doi.org/10.1093/noajnl/vdab109

Ejemplares similares

DIPG-50. A NOVEL ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL OF RADIATION-INDUCED GLIOMA
por: Whitehouse, Jacqueline, et al.
Publicado: (2020)

RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN
por: Buck, Jessica, et al.
Publicado: (2020)

A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2020)

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021)

RONC-07. Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models
por: Whitehouse, Jacqueline, et al.
Publicado: (2022)

Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets
por: Abbas, Zahra, et al.
Publicado: (2022)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA
por: Abbas, Zahra, et al.
Publicado: (2023)

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2023)

Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
por: Rajagopal, Revathi, et al.
Publicado: (2023)

A novel technique of serial biopsy in mouse brain tumour models
por: Rogers, Sasha, et al.
Publicado: (2017)

OTME-3. Dissection of the role of stromal microenvironment and tumor-TME crosstalk in pediatric brain cancer
por: Federico, Aniello, et al.
Publicado: (2021)

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
por: Andradas, Clara, et al.
Publicado: (2021)

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation
por: van Vuurden, Dannis G., et al.
Publicado: (2011)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

IDH1/IDH2 Mutations Define the Prognosis and Molecular Profiles of Patients with Gliomas: A Meta-Analysis
por: Zou, Peng, et al.
Publicado: (2013)

Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
por: Gill, Suki, et al.
Publicado: (2022)

Physical and Molecular Landscapes of Mouse Glioma Extracellular Vesicles Define Heterogeneity
por: Gyuris, Aron, et al.
Publicado: (2019)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis
por: van Kempen, Evi J., et al.
Publicado: (2021)

Molecular and clinicopathologic features of gliomas harboring NTRK fusions
por: Torre, Matthew, et al.
Publicado: (2020)

Educational Case: Histologic and Molecular Features of Diffuse Gliomas
por: Zhang, Sarah, et al.
Publicado: (2020)

MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura, et al.
Publicado: (2021)

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma
por: DeSisto, John, et al.
Publicado: (2021)

Combining molecular targeted agents with radiation therapy for malignant gliomas
por: Scaringi, Claudia, et al.
Publicado: (2013)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers
por: Arcella, Antonietta, et al.
Publicado: (2020)

The molecular feature of macrophages in tumor immune microenvironment of glioma patients
por: Zhang, Hao, et al.
Publicado: (2021)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric Gliomas
por: Dasgupta, Tina, et al.
Publicado: (2013)

Correlation of Molecular Markers in High Grade Gliomas with Response to Chemo-Radiation
por: Khurana, Rohini, et al.
Publicado: (2020)

From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
por: Dewdney, Brittany, et al.
Publicado: (2023)

The association of diabetes with risk of prostate cancer defined by clinical and molecular features
por: Feng, Xiaoshuang, et al.
Publicado: (2020)

Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Identification of the Gene Expression Rules That Define the Subtypes in Glioma
por: Cai, Yu-Dong, et al.
Publicado: (2018)

A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas
por: Mallick, Supriya, et al.
Publicado: (2022)

Molecular dissection of ependymomas
por: Pajtler, Kristian W., et al.
Publicado: (2015)

Molecular and clinical features of a potential immunotherapy target ELK3 in glioma
por: Xu, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jpg2im3j7d5mugdehlnk2712c0